BioMed Research International

BioMed Research International / 2016 / Article
Special Issue

Upstream and Downstream of Recombinants Biomolecules to Health Care Industry

View this Special Issue

Research Article | Open Access

Volume 2016 |Article ID 3073949 |

Biaosheng Lin, Zhijuan Li, Huixia Zhang, Jiangwen Wu, Maochun Luo, "Cloning and Expression of the γ-Polyglutamic Acid Synthetase Gene pgsBCA in Bacillus subtilis WB600", BioMed Research International, vol. 2016, Article ID 3073949, 7 pages, 2016.

Cloning and Expression of the γ-Polyglutamic Acid Synthetase Gene pgsBCA in Bacillus subtilis WB600

Academic Editor: Jorge G. Farías
Received01 Dec 2015
Revised23 Feb 2016
Accepted02 Mar 2016
Published17 Mar 2016


To clone and express the γ-polyglutamic acid (γ-PGA) synthetase gene pgsBCA in Bacillus subtilis, a pWB980 plasmid was used to construct and transfect the recombinant expression vector pWB980-pgsBCA into Bacillus subtilis WB600. PgsBCA was expressed under the action of a P43 promoter in the pWB980 plasmid. Our results showed that the recombinant bacteria had the capacity to synthesize γ-PGA. The expression product was secreted extracellularly into the fermentation broth, with a product yield of 1.74 g/L or higher. γ-PGA samples from the fermentation broth were purified and characterized. Hydrolysates of γ-PGA presented in single form, constituting simple glutamic acid only, which matched the characteristics of the infrared spectra of the γ-PGA standard, and presented as multimolecular aggregates with a molecular weight within the range of 500–600 kDa. Expressing the γ-PGA synthetase gene pgsBCA in B. subtilis system has potential industrial applications.

1. Introduction

Gamma-polyglutamic acid (γ-PGA) is a new water-soluble biodegradable material. It is an anionic polypeptide formed by the condensation of amide linkages between α-amino and γ-carboxylic acid groups of the D- and/or L-glutamate in microorganisms. It has nontoxic, edible, adhesive, film-forming, and moisture retention properties [1]. γ-PGA and its derivatives can be used as drug carriers and bioadhesive materials that have been widely used in pharmaceutical, cosmetics, food, agriculture, and sewage treatment industries and have become one of the most interesting topics in biopolymer research [2].

Traditionally, γ-PGA is primarily produced through microbial fermentation [3]. Bacteria involved in γ-PGA synthesis are mostly gram-positive (genus: Bacillus, class: Bacilli) and are classified as glutamate-dependent or glutamate nondependent types based on their needs for glutamate [4]. Wild-type γ-PGA-producing strains have unstable heritability, easily leading to a reduction or loss in the ability to synthesize γ-PGA during fermentation, undergo γ-PGA degradation, and produce extracellular polysaccharide by-products, thereby lowering product yield. Compared to traditional mutation breeding, genetic engineering technologies have been expected to become an effective method to create γ-PGA high-yield strains. Ashiuchi et al. [5] and Tarui et al. [6] confirmed that pgsB, pgsC, and pgsA are three essential genes involved in γ-PGA synthesis in glutamate-dependent strains. Urushibata et al. [7] and Jiang et al. [8] constructed recombinant plasmids containing the pgsBCA gene through different methods of fusion expression and further transformed the plasmids into Escherichia coli to obtain positive clones that were capable of producing γ-PGA. E. coli, a gram-negative bacterium, has been reported as the primary host strain for transforming the recombinant vector of the γ-PGA synthase gene. However, its synthase gene is mainly derived from Bacillus subtilis (gram-positive bacteria). The membrane structures and protein secretion systems of both types of bacteria vary, which in turn may result in poor positioning of the recombinant expressed γ-PGA synthase system on the bacterial cell membrane [9]. Therefore, the level of expression of γ-PGA in the host strain is lower; and the amount of γ-PGA obtained from positive clones is only within the range of 0.024–0.134 g/L [10]. B. subtilis, as a prokaryotic expression host for food safety, carries some excellent features in expressing γ-PGA that E. coli does not possess. For example, B. subtilis is capable of expressing the soluble and nonfusion proteins, as well as preferentially expressing the nonpathogenic and nonapparent codons [11]. In addition, its expression of a recombinant plasmid after transformation is high. Therefore, its expression products have greater advantages and higher potential in manufacturing biological engineering products for the food and pharmaceutical industries. However, the relevant study of cloning and expression of pgsBCA in B. subtilis was comparatively scarce. To date, the expression of the γ-PGA synthase gene pgsBCA still need D-xylose and L-arabinose induced, generally with poor expression yield and low molecular weight (only 200–500 kDa) [12], indicating the need to resolve this particular bottleneck. Considering this, in this paper, the recombinant plasmid expressing pgsBCA gene was reconstructed and highly expressed in B. subtilis as to improve the yield and molecular weight of γ-PGA. B. subtilis 168 has been widely used in the study of γ-PGA regulation. It is one of the few bacterial strains that has a complete set of γ-PGA synthase genes but does not produce γ-PGA [13]. The present study used the genomic DNA of B. subtilis 168 as DNA template to amplify the γ-PGA synthase gene pgsBCA and to further clone the pgsBCA gene into the B. subtilis expression vector pWB980 to transform into type strain B. subtilis WB600. We constructed a recombinant B. subtilis expression system for γ-PGA synthesis, which may serve as a foundation for the high-yield industrial production of γ-PGA based on an engineered B. subtilis expression system.

2. Materials and Methods

2.1. Bacterial Strains and Plasmids

B. subtilis 168 and B. subtilis WB600 were purchased from Shanghai Genemy BioTech Co., Ltd. (Shanghai, China); E. coli JM109 was prepared and preserved at our laboratory and described in a previous study. pMD19-T vector and B. subtilis expression vector pWB980 were purchased from TakaRa Biotechnology (Dalian) Co., Ltd. (Dalian, China).

2.2. Reagents

All restriction endonucleases, T4 DNA ligase, Taq DNA polymerase, dNTPs, DNA ladder marker, and protein molecular weight markers, were purchased from TakaRa Biotechnology (Dalian) Co., Ltd. Plasmid extraction and agarose DNA extraction kits were purchased from Tiangen Biotech (Beijing) Co., Ltd. (Beijing, China). Bacterial genomic DNA extraction kits were purchased from and primers were designed and synthesized by Sangon Biotech (Shanghai) Co., Ltd. (Shanghai, China). Silica gel plates for thin layer chromatography (TLC) were purchased from Qingdao Jiyida Silica Reagent Factory (Model number: 50 × 100 GF254, Shandong, China).

2.3. Culture Medium

Lysogeny broth (LB) was prepared using 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl (pH 7.0) and 2.0% (W/V) agar powder to solidify the medium. E. coli and B. subtilis transformants were selected with 50 μg/mL ampicillin () and 30 μg/mL kanamycin (), respectively. Fermentation broth for the genetically engineered recombinant bacteria contained 40 g/L glucose, 0–100 g/L sodium glutamate, 6 g/L (NH4)2SO4, 2 g/L K2HPO4, and 0.2 g/L MgSO4 (pH 7.5).

2.4. Primer Design

With reference to the NCBI database, the upstream and downstream pgsB, pgsC, and pgsA coding gene sequences of B. subtilis 168 were designed as follows: BAC1: 5′-CGCGGATCCATGTGGTTACTCATFATAGCC-3′ (restriction site of BamHI endonuclease is underlined); BAC2: 5′-CCCA AGCTTTTATTTAGATTTTAGTTTGTCA C-3′ (restriction site of HindIII endonuclease is underlined).

2.5. Cloning of γ-PGA Synthetase Gene

B. subtilis 168 genomic DNA was used as template. BAC1 and BAC2 primers were used to amplify the gene. The PCR reaction system included 2 μL of DNA template, 10 μL of 5x buffer, 2 μL of dNTPs, 2 μL of individual primers of BAC1 and BAC2, 0.5 μL of 5x Primer STAR, and sterile double-distilled water to prepare a final volume of 50 μL. Reaction conditions were as follows: 94°C for 3 min, followed by 30 cycles of 94°C for 30 s, 55°C for 15 s, and 72°C for 3 min, and a final 72°C extension for 10 min. One percent agarose gel electrophoresis was used to identify the PCR reaction products. PCR products were recovered using a DNA rapid recovery reagent and ligated into the pMD19-T vector, which was followed by transformation into E. coli JM109 competent cells using CaCl2 methods. The selected single colonies were inoculated into liquid LB to expand the plasmid. Intermediate vectors pMD-pgsBCA were then obtained and identified using BamHI and HindIII double digestion as well as sequencing.

2.6. Construction of B. subtilis Expression Vector

BamHI and HindIII double digestion was performed to cut the intermediate vector pMD-T-pgsBCA and pWB980 plasmid, followed by ligating these into the recombinant expression vector, pWB980-pgsBCA (Figure 1). Kanamycin resistance screening was performed to screen the recombinant plasmid, followed by plasmid extraction and identification using restriction enzyme digestion and sequencing to obtain the positive clones of the bacterial strain.

2.7. Induced Expression of pgsBCA Gene

pWB980-pgsBCA plasmids were transformed into B. subtilis WB600 to obtain recombinant strains of Bacillus WB600-pgsBCA, which were inoculated into 5 mL of fresh liquid LB containing 30 μg/mL kanamycin and incubated at 37°C in a 200 rpm shaker overnight. The next day, a 2% inoculum of the culture suspension was further inoculated into 250 mL flask with 100 mL recombinant fermentation medium containing kanamycin and incubated at 37°C in a 200 rpm shaker for 36–48 h until the bacterial concentration stopped growing and fermentation was terminated. pWB980-pgsBCA contained a constitutive P43 promoter. Hence, we did not add any inducers during the fermentation process. Approximately 0–100 g/L sodium glutamate was added into the fermentation medium as a synthetic substrate for γ-PGA to further study the impact of different substrate concentrations on the synthetic yield of γ-PGA.

2.8. γ-PGA Isolation and Purification

After adding the optimal substrate concentration and fermentation had ended, the fermentation medium was centrifuged at 5,000 rpm for 5 min to collect the supernatant. The supernatant was mixed with 4 volumes of absolute ethanol and left to stand overnight at 4°C, followed by centrifugation at 4,000 rpm, and then the supernatant was discarded. The pellet was redissolved in the appropriate amount of distilled water and further centrifuged at 5,000 rpm to obtain the supernatant. A 20 mg/mL solution of proteinase K was added into the supernatant and dialyzed overnight using deionized water. After the centrifugation as earlier described, the supernatant was collected and freeze-dried to obtain the purified solid samples of γ-PGA. γ-PGA samples were stored at −70°C until analysis.

2.9. Hydrolysis of γ-PGA

A 0.5 g purified γ-PGA sample was added to 10 mL of 6 moL/L HCl, vacuumed for 10 min, and then sealed. The sample was then hydrolyzed at 110°C for 12–24 h, allowed to cool down and then filtered, and redissolved in 6 moL/L of NaOH to adjust the pH to 7.0. The aqueous solution was transferred to a 100 mL flask, and the hydrolysate was subjected to TLC using silica gel plates to analyze its amino acid composition.

2.10. Determination of γ-PGA Contents and Properties

γ-PGA contents of fermentation broth were measured by high-performance liquid chromatography (HPLC) [14]. The purified γ-PGA samples underwent infrared spectroscopy using Shimadzu’s IR Prestige-21 infrared spectrometer, Shimadzu (China) Co., Ltd. (Beijing, China). Potassium bromide (KBr) was used as reference material [15]. The molecular weight of γ-PGA was determined by SDS-PAGE [16].

3. Results

3.1. PCR Amplification and Identification of γ-PGA Synthetase Gene pgsBCA

The target gene was amplified by PCR. Figure 2 shows the PCR products that were separated and analyzed using agarose gel electrophoresis. The observed size of the amplified pgsBCA fragment, 2.8 kb, was in agreement with our expected results. An agarose DNA extraction kit was used to recover and purify the PCR products. After confirming with DNA sequencing, the DNA sequence of the PCR products was determined to be 100% identical with the sequence of the reported gene of B. subtilis 168.

3.2. Identification of B. subtilis Expression Vectors

After transforming the constructed recombinant expression vectors, pWB980-pgsBCA, into competent cells, the plasmids were collected and identified using BamHI and HindIII restriction enzyme digestions. Figure 3 shows that, as shown in the map of double restriction enzyme digestions, the size of the cleaved fragment was the same as that of the pgsBCA PCR products, thereby initially confirming the successful construction of the recombinant expression vector, pWB980-pgsBCA.

3.3. Impact of Different Substrate Concentrations on the Synthetic Yield of γ-PGA

Figure 4 shows that, with increasing amounts of the substrate, glutamate, the production of γ-PGA was enhanced. However, when glutamate concentration was >50 g/L, the synthetic yield of γ-PGA declined. This result suggested that pgsBCA was secreted by B. subtilis WB600. The expressed product, γ-PGA, could be secreted into extracellular fermentation broth. Using a lower substrate concentration, we observed that the recombinant bacteria did not synthesize γ-PGA, indicating that an excess amount of substrate was necessary for the recombinant bacteria to synthesize γ-PGA. Therefore, from the perspective of economic efficiency, we identified that a substrate concentration of 50 g/L was optimal to synthesize the highest possible amount of γ-PGA (1.74 g/L).

3.4. Characterization of Recombinant γ-PGA in Fermentation Broth

Figure 5 shows the TLC results of the hydrolysate samples observed under ultraviolet light, wherein, after the acid hydrolysis of γ-PGA, no other band was observed on the silica gel plates but only single spots of uniform color intensity. Its retention () value was consistent with that of the standard, glutamate spots, indicating that the hydrolysates had no other amino acids and other protein impurities. These hydrolysates were in single form, solely consisting of pure glutamic acid. Figure 6 shows the infrared (IR) spectroscopy of γ-PGA. The absorption peak at 3,421 cm−1 was the symmetric stretching vibration band of N-H; and the absorption peak at 1,649 cm−1 was the asymmetric stretching vibration band of an amide group, -CONHR. Both peaks were the main indicators used in the identification of amides and for the presence of amide groups in γ-PGA molecules. The absorption peak at 1,408 cm−1 was the symmetric stretching vibration band of COOH; the absorption peak at 1,076 cm−1 was the hallmark peak representing the presence of aliphatic hydrocarbons, -CH2 or -CH3 (flexural vibration), in the molecular structure; and the absorption peaks within the range of 1,000 cm−1–500 cm−1 were caused by the (CH2)n () planar rocking vibration, as well as in-plane bending vibration. The spectral characteristics of recombinant γ-PGA in fermentation broth was consistent with those of the standard γ-PGA’s IR spectroscopy, indicating that the sample obtained in the present study contained the N-H and C=O functional groups, as well as the aliphatic hydrocarbon structure (CH2)4 of the γ-PGA [17], thereby confirming that the sample was γ-PGA. The molecular weight of the γ-PGA sample obtained after the fermentation, isolation, and separation of recombinant strain Bacillus WB600-pgsBCA was determined using SDS-PAGE. Figure 7 shows that the molecular weight of the γ-PGA was between 500 and 600 kDa and occurred as aggregates of a multimolecular mass, but not of a single molecular composition.

4. Discussion and Conclusions

The present study evaluated the cloning and expression of γ-PGA synthase gene pgsBCA in B. subtilis and used plasmid pWB980 to construct the recombinant expression vector, pWB980-pgsBCA, and to further transfer the recombinant expression vector into B. subtilis WB600. The P43 promoter of pWB980 induced the expression of pgsBCA; then the host cells of this expression vector showed a capacity to synthesize γ-PGA, and the product yield of γ-PGA reached ≥1.74 g/L. The isolated and purified γ-PGA sample from the fermentation broth was confirmed to have a single form of hydrolysates that solely consisted of pure glutamic acid. This result matched the characteristics of the standard γ-PGA’s IR spectroscopy and showed the aggregates of a multimolecular mass, with a molecular weight ranging between 500 and 600 kDa.

The present study used B. subtilis as the expression host, and the pgsBCA gene originated and was expressed in B. subtilis. The γ-PGA synthase system is better positioned in the cell membrane (as shown in Section 1). Therefore, the synthetic yield and molecular weight of γ-PGA produced in B. subtilis were as high as ≥1.74 g/L and between 500 and 600 kDa, two features that are consistent with or even higher than the expression system of E. coli and B. subtilis that had previously been described to have high expression efficiency [1820]. The molecular weight of γ-PGA especially expressed in this host is the highest in the existing report [2124]. The recombinant expression vector, pWB980-pgsBCA, in the present study contained the P43 promoter. Therefore, the costly use of isopropyl β-D-1-thiogalactopyranoside (IPTG), D-xylose, and L-arabinose as an inducer to secrete the pgsBCA into the extracellular fermentation broth is circumvented using the methodology developed in the present study. This technique may also be potentially used in industrial production as it can increase the stability of products, simplify the purification work, and have more obvious application potential advantage.

Although the constructed recombinant bacteria Bacillus WB600-pgsBCA showed the capacity to synthesize γ-PGA, our results still could not match the highest synthetic yield of γ-PGA (40–50 g/L) that is induced by the fermentation of mutated bacteria [25, 26]. Therefore, our next research study will focus on introducing hemoglobin, other exogenous genes, or certain control sequences to efficiently synthesize and express γ-PGA and to increase the bacterial concentration, oxygen uptake, or endogenous synthase expression, thereby ultimately increasing γ-PGA yield [27, 28]. Alternatively, we will knock out genes of degrading enzymes in γ-PGA-producing strains to reduce γ-PGA degradation, thereby increasing γ-PGA yield [29]. Therefore, our future research direction and goal will focus on establishing and modifying our current engineered strains through genetic engineering to improve its performance and further increase γ-PGA yield, thereby laying the foundation for the industrial production of high-yielding γ-PGA engineered bacteria based on the B. subtilis expression system.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


This study was supported by the Student Innovation & Entrepreneurship Training Program in Fujian Province (no. 201511312053), JK Project for the Department of Science and Technology of Fujian Province (no. JK2014051), and Science and Technology Planning Project of Longyan City (no. 2015LY32).


  1. R. Bhatt, P. De Vries, J. Tulinsky et al., “Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20(S)-camptothecin,” Journal of Medicinal Chemistry, vol. 46, no. 1, pp. 190–193, 2003. View at: Publisher Site | Google Scholar
  2. T. Candela and A. Fouet, “Poly-gamma-glutamate in bacteria,” Molecular Microbiology, vol. 60, no. 5, pp. 1091–1098, 2006. View at: Publisher Site | Google Scholar
  3. P. Dubruel, L. Dekie, B. Christiaens et al., “Poly-L-glutamic acid derivatives as multifunctional vectors for gene delivery: part B. biological evaluation,” Biomacromolecules, vol. 4, no. 6, p. 1868, 2003. View at: Google Scholar
  4. A. Richard and A. Margaritis, “Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers,” Biotechnology and Bioengineering, vol. 87, no. 4, pp. 501–515, 2004. View at: Publisher Site | Google Scholar
  5. M. Ashiuchi, C. Nawa, T. Kamei et al., “Physiological and biochemical characteristics of poly-γ-glutamate synthetase complex of Bacillus subtilis,” European Journal of Biochemistry, vol. 268, no. 20, pp. 5321–5328, 2001. View at: Publisher Site | Google Scholar
  6. Y. Tarui, H. Iida, E. Ono et al., “Biosynthesis of poly-γ-glutamic acid in plants: transient expression of poly-γ-glutamate synthetase complex in tobacco leaves,” Journal of Bioscience and Bioengineering, vol. 100, no. 4, pp. 443–448, 2005. View at: Publisher Site | Google Scholar
  7. Y. Urushibata, S. Tokuyama, and Y. Tahara, “Difference in transcription levels of cap genes for γ-polyglutamic acid production between Bacillus subtilis IFO 16449 and Marburg 168,” Journal of Bioscience and Bioengineering, vol. 93, no. 2, pp. 252–254, 2002. View at: Publisher Site | Google Scholar
  8. H. Jiang, L. Shang, S. H. Yoon, S. Y. Lee, and Z. Yu, “Optimal production of poly-γ-glutamic acid by metabolically engineered Escherichia coli,” Biotechnology Letters, vol. 28, no. 16, pp. 1241–1246, 2006. View at: Publisher Site | Google Scholar
  9. J. M. Buescher and A. Margaritis, “Microbial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries,” Critical Reviews in Biotechnology, vol. 27, no. 1, pp. 1–19, 2007. View at: Publisher Site | Google Scholar
  10. S. F. Wang, J. He, Y. L. Chen, T. Zheng, Q. R. Shen, and X. Y. Yong, “Clone and heterologous expression of the ploy-γ-glutamic acid synthesis gene pgsBCAF from Bacillus amyloliquefaciens C1,” Chinese Journal of Biotechnology Bulletin, vol. 31, no. 5, pp. 158–166, 2015. View at: Google Scholar
  11. L. Vavrová, K. Muchová, and I. Barák, “Comparison of different Bacillus subtilis expression systems,” Research in Microbiology, vol. 161, no. 9, pp. 791–797, 2010. View at: Publisher Site | Google Scholar
  12. M. Ashiuchi, K. Shimanouchi, T. Horiuchi, T. Kamei, and H. Misono, “Genetically engineered poly-γ-glutamate producer from Bacillus subtilis ISW1214,” Bioscience, Biotechnology & Biochemistry, vol. 70, no. 7, pp. 1794–1797, 2006. View at: Publisher Site | Google Scholar
  13. T. Yan and H. S. Xi, “Progresses of microbial synthesis of poly-γ-glutamic acid of related genes, synthesis mechanism and fermentation,” Chinese Journal of Biotechnology Bulletin, vol. 31, no. 3, pp. 25–34, 2015 (Chinese). View at: Google Scholar
  14. Q. J. Wang, S. W. Chen, J. B. Zhang, M. Sun, Z. D. Liu, and Z. N. Yu, “Co-producing lipopeptides and poly-γ-glutamic acid by solid-state fermentation of Bacillus subtilis using soybean and sweet potato residues and its biocontrol and fertilizer synergistic effects,” Bioresource Technology, vol. 99, no. 8, pp. 3318–3323, 2008. View at: Publisher Site | Google Scholar
  15. Y.-G. Liu, Q.-L. Dai, S.-B. Wang, Q.-J. Deng, W.-G. Wu, and A.-Z. Chen, “Preparation and in vitro antitumor effects of cytosine arabinoside-loaded genipin-poly-L-glutamic acid-modified bacterial magnetosomes,” International Journal of Nanomedicine, vol. 10, pp. 1387–1397, 2015. View at: Publisher Site | Google Scholar
  16. G. J. Qiao, C. Wang, Z. H. Zhou, K. Zhang, and H. Cai, “Clone and expression of poly-glutamic acid synthase gene in Escherichia coli,” Chinese Journal of Food and Fermentation Technology, vol. 49, no. 1, pp. 7–12, 2013 (Chinese). View at: Google Scholar
  17. M. Ashiuchi and H. Misono, “Biochemistry and molecular genetics of poly-γ-glutamate synthesis,” Applied Microbiology and Biotechnology, vol. 59, no. 1, pp. 9–14, 2002. View at: Publisher Site | Google Scholar
  18. M. Cao, W. Geng, W. Zhang et al., “Engineering of recombinant Escherichia coli cells co-expressing poly-γ-glutamic acid (γ-PGA) synthetase and glutamate racemase for differential yielding of γ-PGA,” Microbial Biotechnology, vol. 6, no. 6, pp. 675–684, 2013. View at: Publisher Site | Google Scholar
  19. M. Ashiuchi, K. Soda, and H. Misono, “A poly-γ-glutamate synthetic system of Bacillus subtilis IFO 3336: gene cloning and biochemical analysis of poly-γ-glutamate produced by Escherichia coli clone cells,” Biochemical and Biophysical Research Communications, vol. 263, no. 1, pp. 6–12, 1999. View at: Publisher Site | Google Scholar
  20. J. Huang, Y. M. Du, G. H. Xu et al., “High yield and cost-effective production of poly(γ-glutamic acid) with Bacillus subtilis,” Engineering in Life Sciences, vol. 11, no. 3, pp. 291–297, 2011. View at: Publisher Site | Google Scholar
  21. M. Cao, C. Song, Y. Jin et al., “Synthesis of poly (γ-glutamic acid) and heterologous expression of pgsBCA genes,” Journal of Molecular Catalysis B: Enzymatic, vol. 67, no. 1-2, pp. 111–116, 2010. View at: Publisher Site | Google Scholar
  22. M. Cao, W. Geng, L. Liu et al., “Glutamic acid independent production of poly-γ-glutamic acid by Bacillus amyloliquefaciens LL3 and cloning of pgsBCA genes,” Bioresource Technology, vol. 102, no. 5, pp. 4251–4257, 2011. View at: Publisher Site | Google Scholar
  23. S. B. Da Silva, V. V. Cantarelli, and M. A. Z. Ayub, “Production and optimization of poly-γ-glutamic acid by Bacillus subtilis BL53 isolated from the Amazonian environment,” Bioprocess & Biosystems Engineering, vol. 37, no. 3, pp. 469–479, 2014. View at: Publisher Site | Google Scholar
  24. W. Zhang, W. X. Gao, J. Feng et al., “A markerless gene replacement method for B. amyloliquefaciens LL3 and its use in genome reduction and improvement of poly-γ-glutamic acid production,” Applied Microbiology and Biotechnology, vol. 98, no. 21, pp. 8963–8973, 2014. View at: Publisher Site | Google Scholar
  25. C. S. Qiao, X. Li, L. F. Lan, X. Chen, Z. W. Zheng, and Z. Li, “Screening of a high-yield of γ-ployglutamic acid-producing strain by means of both UV light and He-Ne laser,” Chinese Journal of Food Science, vol. 33, no. 13, pp. 183–186, 2012 (Chinese). View at: Google Scholar
  26. B. S. Lin, F. Y. Qiu, Q. X. Lin, and Y. P. Hong, “Optimization of breeding and cultivation conditions for mutant strain with high productivity of γ-polyglutamic acid,” Journal of Pure and Applied Microbiology, vol. 7, no. 4, pp. 2479–2488, 2013. View at: Google Scholar
  27. C.-M. Yeh, J.-P. Wang, S.-C. Lo, W.-C. Chan, and M.-Y. Lin, “Chromosomal integration of a synthetic expression control sequence achieves poly-γ-glutamate production in a Bacillus subtilis strain,” Biotechnology Progress, vol. 26, no. 4, pp. 1001–1007, 2010. View at: Publisher Site | Google Scholar
  28. Y. Su, X. Li, Q. Liu et al., “Improved poly-γ-glutamic acid production by chromosomal integration of the Vitreoscilla hemoglobin gene (vgb) in Bacillus subtilis,” Bioresource Technology, vol. 101, no. 12, pp. 4733–4736, 2010. View at: Publisher Site | Google Scholar
  29. J. Feng, W. X. Gao, Y. Y. Gu et al., “Functions of poly-gamma-glutamic acid (γ-PGA) degradation genes in γ-PGA synthesis and cell morphology maintenance,” Applied Microbiology and Biotechnology, vol. 98, no. 14, pp. 6397–6407, 2014. View at: Publisher Site | Google Scholar

Copyright © 2016 Biaosheng Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.